Downloadable Slidesets

Share

Program Content

Activities

  • 1L: High-Risk Patient
    Cases in CLL Slides: High-Risk Patient Requiring First-line Therapy
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 28, 2020

    Expires: September 27, 2021

  • 1L: Fit Patient
    Cases in CLL Slides: Fit, Younger Patient Requiring First-line Therapy
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 28, 2020

    Expires: September 27, 2021

  • 1L: Older Patient
    Cases in CLL Slides: Options for an Older Patient Requiring First-line Therapy
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 12, 2020

    Expires: October 11, 2021

  • 2L: Post CIT
    Cases in CLL Slides: Second-Line Therapy Following Chemoimmunotherapy
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 28, 2020

    Expires: September 27, 2021

  • 2L+: Ibrutinib Intolerance
    Cases in CLL Slides: Patient Progressing on BR With Subsequent Ibrutinib Intolerance
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 01, 2020

    Expires: September 30, 2021

  • 3L: Post BTKi/VenR
    Cases in CLL Slides: Third-line Treatment Following BTK Inhibitor– and Venetoclax-Based Therapy
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 14, 2020

    Expires: October 13, 2021

Provided by

ProCE Banner

Supporters

AbbVie Inc.

AstraZeneca

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pharmacyclics an AbbVie Company

Partners

CLL Society

ProCE Banner